2001-August Archives by Subject

• Messages sorted by: [ thread ] [ author ] [ date ]
• More info on this list...

Starting: Fri Aug 3 13:48:03 2001
Ending: Fri Aug 31 18:41:09 2001
Messages: 102

• [Pharm-policy] (no subject)   Kermit Johnson
• [Pharm-policy] (no subject)   B Garcia
• [Pharm-policy] (no subject)   Joel Lexchin
• [Pharm-policy] [Fwd: Pfizer donates Diflucan to 50 countries]   Ron Macinnis
• [Pharm-policy] ACTION ALERT: Call Senators & demand $2 billion for the Global AIDS Fund   Paul Davis
• [Pharm-policy] affordcd4.com   James Love
• [Pharm-policy] Amir, IIPI and Boston Globe on patents in Africa   James Love
• [Pharm-policy] Amir, IIPI and Boston Globe on patents in Africa   James Love
• [Pharm-policy] Andrew Pollack on Genentech royalty dispute   James Love
• [Pharm-policy] Another report on Brazil   James Love
• [Pharm-policy] Another US bill on parallel imports   James Love
• [Pharm-policy] Babelfish on Tribune de Geneve article   James Love
• [Pharm-policy] Babelfish translation of LeMonde article on German Velasquez   James Love
• [Pharm-policy] Bill Haddad on Polish data exclusivity   James Love
• [Pharm-policy] Boston Globe on NIH royalties for drug R&D   Mike Palmedo
• [Pharm-policy] Brazil and Roche resume talks   Mike Palmedo
• [Pharm-policy] Brazil annouces compulsory license for nelfinavir   Mike Palmedo
• [Pharm-policy] Brazil Ministry of Health's August 22 announcement of compulsory licensing of Nelfinavir patent   James Love
• [Pharm-policy] Brazil Roche   James Love
• [Pharm-policy] Brazil story on Viracept   James Love
• [Pharm-policy] Brazil's threat to break Roche patent on nelfinavir   Paul Davis
• [Pharm-policy] Brook Baker: THE IMPORTANCE OF COMBO-DRUGS: ANOTHER ARGUMENT FOR COMPULSORY AND VOLUNTARY LICENCES   James Love
• [Pharm-policy] China to seek price reductions from AIDS drug makers   James Love
• [Pharm-policy] CIPR website information   Rob Fitter
• [Pharm-policy] Comment on Reporting in Brazil compulsory licensing case   James Love
• [Pharm-policy] Company offers to copyright =?iso-8859-1?Q?people=92s?= DNA against unwanted cloning   James Love
• [Pharm-policy] Econ Times: Zydus to cut prices of AIDS drugs   Mike Palmedo
• [Pharm-policy] Ernst&Young's Report   George M. Carter
• [Pharm-policy] Excise and customs tax lifted on AIDS drugs in India   Mike Palmedo
• [Pharm-policy] for People who have problems posting to the list   James Love
• [Pharm-policy] FT Editorial on Roche/Brazil dispute   James Love
• [Pharm-policy] FTAA Comments from Essential Action   Robert Weissman
• [Pharm-policy] Further dirty tricks in Australia: the battle continues   Ken Harvey
• [Pharm-policy] FW: NATAF: Scholarships Deadline August 31st   Gonsalves, Gregg
• [Pharm-policy] FW: Press statment: Dominican Republic, US trade pressure, and   Paul Davis
• [Pharm-policy] Geron/U of Wisconsin suit over stem cell patents   love@cptech.org
• [Pharm-policy] Good Book on How Generic Entry Affects Pricing   Charisse Basilio
• [Pharm-policy] humor (relevant)   A.J. Peticolas
• [Pharm-policy] Information on equivalence groups   B Garcia
• [Pharm-policy] Lancet: AIDS treatment is possible anywhere in the world.   Paul Davis
• [Pharm-policy] Le Monde on threats against German Velasquez   Manon Ress
• [Pharm-policy] Letter in Support of Thai Government   Robert Weissman
• [Pharm-policy] Licensing Under Trips May Affect Pharma R&D in India   George M. Carter
• [Pharm-policy] Melody Peterson on Brazil/Roche compulsory license   James Love
• [Pharm-policy] Mickey Davis translation of Le Monde on threats against German Velasquez   James Love
• [Pharm-policy] Mickey Davis translation of Le Monde on threats against German Velasquez   Prof. Michael H. Davis
• [Pharm-policy] Multinationals are in control of the Therapeutic Goods Administration   Nelson Para Subramaniam
• [Pharm-policy] New Compulsory License in U.S.   Mike Palmedo
• [Pharm-policy] New policy at major medical journals   katie@CritPath.Org
• [Pharm-policy] NIH report on technology transfer and royalties   Mike Palmedo
• [Pharm-policy] NYT op-ed: Patents Could Block the Way to a Cure   Mike Palmedo
• [Pharm-policy] NYTimes editorial: Stinginess on AIDS   Paul Davis
• [Pharm-policy] On Wisconsin patent on stem cells   James Love
• [Pharm-policy] Online Pharmacies - Indiameds   James Love
• [Pharm-policy] Patent humour   Kate Raworth
• [Pharm-policy] Patent on both hand hair cutting method   James Love
• [Pharm-policy] pharm policy research needs   Paul Waraich
• [Pharm-policy] PhRMA on PC R&D Report   James Love
• [Pharm-policy] Polish dispute over data exclusivity   love@cptech.org
• [Pharm-policy] Price competition in Dominican Republic   James Love
• [Pharm-policy] Project Inform Treatment Action Network Alert   Paul Davis
• [Pharm-policy] Protecting Indigenous Rights   George M. Carter
• [Pharm-policy] Ranbaxy 'victory' in US Courts for GSK generic drug!!   Dwijen Rangnekar
• [Pharm-policy] Ranbaxy Press Release (July)- generic 3TC gets Brazilian approval   Mike Palmedo
• [Pharm-policy] Re: [Ip-health] Amir, IIPI and Boston Globe on patents in Africa   James Love
• [Pharm-policy] Re: [Ip-health] Amir, IIPI and Boston Globe on patents in Africa   amir_attaran@harvard.edu
• [Pharm-policy] Re: [Ip-health] Boston Globe on NIH royalties for drug R&D   Prof. Michael H. Davis
• [Pharm-policy] Re: [Ip-health] Company offers to copyright =?iso-8859-1?Q?people=92s?= DNA againstunwanted cloning   Prof. Michael H. Davis
• [Pharm-policy] Re: [Ip-health] Patent on both hand hair cutting method   calestous_juma@harvard.edu
• [Pharm-policy] Re: [Ip-health] Patent on both hand hair cutting method   Laurie Racine
• [Pharm-policy] Re: [Ip-health] Patent on both hand hair cutting method   calestous_juma@harvard.edu
• [Pharm-policy] Re: [Ip-health] Scope of IP protections and Girl from Ipanema   Prof. Michael H. Davis
• [Pharm-policy] Re: [Ip-health] Sheryl Gay Stolberg in NYT on Patents and Stem Cell Research   Prof. Michael H. Davis
• [Pharm-policy] Re: [Ip-health] Uganda Compulsory licensing case   Prof. Michael H. Davis
• [Pharm-policy] Re: Amir, IIPI and Boston Globe on patents in Africa   Udo Schuklenk
• [Pharm-policy] Re: CIPR website information   Rob Fitter
• [Pharm-policy] Re: Pharm-policy digest, Vol 1 #472 - 1 msg   Alacran7@aol.com
• [Pharm-policy] Re: Pharm-policy digest, Vol 1 #472 - 1 msg   Susan Finston
• [Pharm-policy] Re: Pharm-policy digest, Vol 1 #491 - 3 msgs   janet c collins
• [Pharm-policy] Reuters: Cipla launches 3-in-1 AIDS pill   Mike Palmedo
• [Pharm-policy] Reuters: Roche says Brazil near accord on AIDS drug price   Shadlen, Kenneth
• [Pharm-policy] Reuters: Roche says Brazil near accord on AIDS drug price   Mike Palmedo
• [Pharm-policy] Roche claims Brazil needs notice to USG before enforcing Brazil law   James Love
• [Pharm-policy] Scope of IP protections and Girl from Ipanema   love@cptech.org
• [Pharm-policy] SF Chronicle: Scientists' 'publish or perish' credo now 'patent and profit'   Mike Palmedo
• [Pharm-policy] Sheryl Gay Stolberg in NYT on Patents and Stem Cell Research   love@cptech.org
• [Pharm-policy] TAC/Oxfam/MSF on Reporting on Brazil case   James Love
• [Pharm-policy] TAG Basic Science Project Director job description   Alacran7@aol.com
• [Pharm-policy] test message -- please ignore   A.J. Peticolas
• [Pharm-policy] THE IMPORTANCE OF COMBO-DRUGS: ANOTHER ARGUMENT FOR COMPULSORY AND VOLUNTARY LICENCES   James Love
• [Pharm-policy] Tim Weiner in NYT on Mexican pharmaceutical parallel imports   love@cptech.org
• [Pharm-policy] Timeline of Paclitaxel disputes   James Love
• [Pharm-policy] Tribune de Geneve on WHO's reaction to threats against Velasquez   Manon Ress
• [Pharm-policy] TRIPS Article 30   James Love
• [Pharm-policy] TRIPS Article 30 exceptions to patent rights   James Love
• [Pharm-policy] Uganda Compulsory licensing case   James Love
• [Pharm-policy] UNDUE INFLUENCE: Article from The American Prospect   Gonsalves, Gregg
• [Pharm-policy] uniform patient assistance application   Pat Zerega
• [Pharm-policy] US FTC pursues compulsory license for Unocal anti-smog patents   James Love
• [Pharm-policy] WP: AMA on pharma's gifts to doctors   Mike Palmedo
• [Pharm-policy] WSJ on marketing practices in India   love@cptech.org
• [Pharm-policy] WSJ: Merck-Medco lawsuit   Mike Palmedo

Last message date: Fri Aug 31 18:41:09 2001
Archived on: Fri Aug 31 17:41:09 2001

• Messages sorted by: [ thread ] [ author ] [ date ]
• More info on this list...